| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2025 | Nov 18, 2025 | Seres Therapeutics, Inc. | Officer | Sell | 28.8 | -1,257 | -14.31% | ✓ | $21.7K |
| Aug 15, 2025 | Aug 19, 2025 | Seres Therapeutics, Inc. | Officer | Sell | 50.0 | -73 | -1.58% | ✓ | $1.2K |
| May 15, 2025 | May 19, 2025 | Seres Therapeutics, Inc. | Officer | Sell | 50.0 | -77 | -1.73% | ✓ | $560.6 |
| Feb 15, 2025 | Feb 19, 2025 | Seres Therapeutics, Inc. | Officer | Sell | 42.5 | -3,953 | -4.47% | ✓ | $3.2K |
| Nov 15, 2024 | Nov 19, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 50.0 | -927 | -1.18% | ✓ | $501.2 |
| Oct 27, 2024 | Oct 29, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 42.5 | -3,984 | -4.99% | ✓ | $2.7K |
| Aug 15, 2024 | Aug 19, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 50.0 | -923 | -1.35% | ✓ | $775.3 |
| May 15, 2024 | May 17, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 50.0 | -891 | -1.34% | ✓ | $837.5 |
| Feb 15, 2024 | Feb 16, 2024 | Seres Therapeutics, Inc. | Officer | Sell | 37.5 | -4,170 | -6.17% | ✓ | $4.5K |
| Oct 27, 2023 | Oct 31, 2023 | Seres Therapeutics, Inc. | Officer | Sell | 37.5 | -3,886 | -6.45% | ✓ | $5.2K |
| Dec 1, 2020 | Dec 3, 2020 | Seres Therapeutics, Inc. | Officer | Sell | 5.0 | -91,812 | -100.00% | ✓ | $2.5M |